Insider Trading: Furiex Pharmaceuticals Inc (FURX.O)
FURX.O on Nasdaq
39.49USD
22 May 2013
39.49USD
22 May 2013
Price Change (% chg)
$0.82 (+2.12%)
$0.82 (+2.12%)
Prev Close
$38.67
$38.67
Open
$38.83
$38.83
Day's High
$40.10
$40.10
Day's Low
$38.62
$38.62
Volume
122,897
122,897
Avg. Vol
80,876
80,876
52-wk High
$42.30
$42.30
52-wk Low
$16.57
$16.57
| KALDOR STEPHEN W | Options Exercised: 0 | ||
| Trade Date: | Sunday, 10 Mar 2013 | Price: | 41.74 |
| Title: | Director | Shares Held: | 0 |
| Type Traded: | Direct | Net Change in Shares This Filing: | 0 |
Institutional Holders
| % Shares Owned: | 56.42% |
| # of Holders: | 115 |
| Total Shares Held: | 5,706,807 |
| 3 Mo. Net Change: | 373,800 |
| # New Positions: | 27 |
| # Closed Positions: | 9 |
| # Increased Positions: | 57 |
| # Reduced Positions: | 42 |
| # Net Buyers: | 15 |
Officers & Directors
| Name | Age | Since | Current Position |
|---|---|---|---|
Fredric Eshelman |
63 | 2009 | Chairman of the Board |
June Almenoff |
56 | 2012 | President, Chief Medical Officer, Principal Executive Officer, Director |
Marshall Woodworth |
55 | 2010 | Chief Financial Officer, Treasurer, Assistant Secretary |
Paul Covington |
57 | 2010 | Senior Vice President - Clinical Development and Operations |
Gail McIntyre |
50 | 2010 | Senior Vice President - Research |
Peter Corr |
2010 | Independent Director | |
Wendy Dixon |
56 | 2010 | Independent Director |
Stephen Kaldor |
50 | 2010 | Independent Director |
Robert Ruscher |
52 | 2010 | Independent Director |
Sailash Patel |
Vice President - Strategic Development |

